BACKGROUND: Non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) with initially unresected tumours represent a particular subset of patients with a poor outcome. Various international research groups pooled their data in a joint study in order to investigate prognostic variables and treatment modalities. METHODS: The study population consisted of 304 patients <21 years old treated between 1980 and 2005 using a multimodality therapeutic strategy. RESULTS: Synovial sarcoma and malignant peripheral nerve sheath tumour (MPNST) were the most frequent histotypes. Most patients received initial chemotherapy: major responses were recorded in 41% and minor in 16% of cases. Overall survival (OS) was 60.0% and 51.5% at 5 and 10 years, respectively, and...
2019-04-24Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) are disproportionally represented in the...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
2018-02-10To better understand the risk factors among nonrhabdomyosarcoma soft tissue sarcomas (NRST...
BACKGROUND: Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric...
BACKGROUND: Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric...
Background: A standardised approach to treatment of paediatric non-rhabdomyosarcoma soft tissue sarc...
BACKGROUND. Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric ...
PURPOSE: To assess the value of chemotherapy and radiotherapy in children with malignant peripheral ...
BackgroundTumour grade, tumour size, resection potential, and extent of disease affect outcome in pa...
2018-07-21Malignant peripheral nerve sheath tumors (MPNST) are a rare type of non-rhabdosarcoma soft...
This paper describes the standard of care for patients with non-rhabdomyosarcoma soft tissue sarcoma...
2019-04-13Background: Non‐rhabdomyosarcoma soft tissue sarcomas (NRSTS) are a rare and heterogeneous...
none5noPurpose: Soft tissue sarcomas (STS) of the extremities in children are a heterogeneous group ...
BACKGROUND. Survivors of childhood malignancies have an increased risk of 2 developing second malign...
PurposeSynovial sarcoma (SS) is the second most common malignant soft tissue tumor in children. ARST...
2019-04-24Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) are disproportionally represented in the...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
2018-02-10To better understand the risk factors among nonrhabdomyosarcoma soft tissue sarcomas (NRST...
BACKGROUND: Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric...
BACKGROUND: Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric...
Background: A standardised approach to treatment of paediatric non-rhabdomyosarcoma soft tissue sarc...
BACKGROUND. Treatment of initially unresectable nonrhabdo soft tissue sarcomas (NRSTS) in pediatric ...
PURPOSE: To assess the value of chemotherapy and radiotherapy in children with malignant peripheral ...
BackgroundTumour grade, tumour size, resection potential, and extent of disease affect outcome in pa...
2018-07-21Malignant peripheral nerve sheath tumors (MPNST) are a rare type of non-rhabdosarcoma soft...
This paper describes the standard of care for patients with non-rhabdomyosarcoma soft tissue sarcoma...
2019-04-13Background: Non‐rhabdomyosarcoma soft tissue sarcomas (NRSTS) are a rare and heterogeneous...
none5noPurpose: Soft tissue sarcomas (STS) of the extremities in children are a heterogeneous group ...
BACKGROUND. Survivors of childhood malignancies have an increased risk of 2 developing second malign...
PurposeSynovial sarcoma (SS) is the second most common malignant soft tissue tumor in children. ARST...
2019-04-24Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) are disproportionally represented in the...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
2018-02-10To better understand the risk factors among nonrhabdomyosarcoma soft tissue sarcomas (NRST...